Consent to the Distribution of Changed Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Interferon alpha-2c 3 mcg, 6mcg, 15 mcg per ml Note: This replaces the entry in the notice published in the New Zealand Gazette, 25 November 1993, No. 172, page 3522, notice number 10002. Powder for reconstitution for injection Bender & Co GmbH, Vienna, Austria Berofor Captopril 5 mg/ml in 100 ml Note: This replaces the entry in the notice published in the New Zealand Gazette, 24 March 1994, No. 27, page 1176, notice number 2120. Oral solution Bristol-Myers Squibb Pharmaceuticals Limited, Moreton, Wirral, Merseyside, England Capoten Captopril 12.5 mg, 25 mg, 50 mg Note: This replaces the entry in the notice published in the New Zealand Gazette, 24 March 1994, No. 27, page 1176, notice number 2120. Tablets Bristol-Myers Squibb Pharmaceuticals Limited, Moreton, Wirral, Merseyside, England and Bristol-Myers Squibb Pharmaceuticals Pty Limited, Noble Park, Victoria, Australia Capoten Dated this 13th day of April 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.